Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease

Monitoring of disease activity is essential in patients with inflammatory bowel disease. Although endoscopic remission is the ideal therapeutic goal, noninvasive biomarkers (blood and fecal) are more acceptable to patients and are less costly. We evaluated the performance of combinations of fecal an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mak, Lung-Yi, Tong, Teresa S. M., Cheung, Ka-Shing, Chen, Li-Jia, Lui, Ka-Luen, Lau, Kam-Shing, Leung, Wai K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145039/
https://www.ncbi.nlm.nih.gov/pubmed/32132451
http://dx.doi.org/10.14309/ctg.0000000000000138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145039/
https://www.ncbi.nlm.nih.gov/pubmed/32132451
http://dx.doi.org/10.14309/ctg.0000000000000138

Ejemplares similares